Table 1 |
|||||
|
Summary of analgesic efficacy results |
|||||
|
Number of patients with at least 50% pain relief |
|||||
|
|
|||||
|
Active treatment and dose (mg) |
Number of trials |
Naproxen |
Placebo |
Relative benefit (95% CI) |
NNT (95% CI) |
|
|
|||||
|
Naproxen sodium 550 |
6 |
127/252 |
30/248 |
4.2 (2.9 to 6.0) |
2.6 (2.2 to 3.2) |
|
Naproxen sodium/naproxen 440/400 |
3 |
103/210 |
14/124 |
4.8 (2.8 to 8.3) |
2.7 (2.2 to 3.5) |
|
Naproxen sodium/naproxen 220/200 |
2 |
54/120 |
13/82 |
2.9 (1.6 to 5.1) |
3.4 (2.4 to 5.8) |
|
|
|||||
|
Mason et al. BMC Anesthesiology 2003 3:4 doi:10.1186/1471-2253-3-4 |
|||||